Citations 1
Addressing Skin Adverse Events during Mirdametinib Treatment in Patients with Neurofibromatosis Type 1-Associated Plexiform Neurofibromas: Guidance from Experts on the Management of MEK Inhibitor-Associated Skin AEs
Hirbe, A., Anadkat, M., Boull, C., Nickerson, M., Weber, M., Babovic-Vuksanovic, D., Gershon, T., Hirbe, Angela C. , Anadkat, Milan J. , Boull, Christina , Babovic‐Vuksanovic, Dusica , Gershon, Timothy R.
Neuropediatrics | April 27, 2026 | Volume: 57 | Issue: No issue available | Pages: No page available
